HARBIN, China, Sept. 25 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. , a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People’s Republic of China (“PRC”), announced that it held its Annual Meeting of Shareholders (the “AMS”) on September 24th, 2009, in Harbin, China.
At the meeting, a proposal for the election of seven directors to serve until the AMS in 2010 was approved by a majority of shares outstanding and entitled to vote, by proxy or in person. Specifically, shareholders elected Mr. Yan-qing Liu, Ms. Xiao-yan Han, Mr. Yu-bo Hao, Mr. Chun-fang Song, Ms. Xu-feng Qian, Mr. Jie Zhao, and Mr. William Wei Lee as members of the Board of Directors of the Company.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company (“TDR”), Harbin First Bio-Engineering Company Limited (“First”), Heilongjiang Tianlong Pharmaceutical, Inc. (“Tianlong”) and Peng Lai Jin Chuang Pharmaceutical Company (“Jin Chuang”) the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .
SOURCE China Sky One Medical, Inc.
CONTACT: Company Contact: China Sky One Medical, Inc., Mr. Stanley Hao,
CFO, +86-451-5399-4069, or stanleyhao@cski.com.cn; Or Investor Relations
Contact: CCG Investor Relations, Mr. Crocker Coulson, President,
+1-646-213- 1915, or crocker.coulson@ccgir.com
Web site: http://www.cski.com.cn/
http://www.ccgirasia.com/
